Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study Group. [electronic resource]
Producer: 19981209Description: 155-61 p. digitalISSN:- 8755-6863
- Administration, Inhalation
- Adolescent
- Adult
- Child
- Child, Preschool
- Cystic Fibrosis -- drug therapy
- Deoxyribonuclease I -- administration & dosage
- Expectorants -- administration & dosage
- Female
- Humans
- Male
- Middle Aged
- Prospective Studies
- Recombinant Proteins -- administration & dosage
- Respiratory Function Tests
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.